{"id":"https://openalex.org/W7225733257","doi":"https://doi.org/10.3389/fcvm.2026.1991282","title":"Early blood pressure, cardiac biomarker, and strain changes for risk stratification of cardiovascular toxicity during VEGFR-TKI therapy: a cardio-oncology cohort study","display_name":"Early blood pressure, cardiac biomarker, and strain changes for risk stratification of cardiovascular toxicity during VEGFR-TKI therapy: a cardio-oncology cohort study","publication_year":2026,"publication_date":"2026-11-10","ids":{"openalex":"https://openalex.org/W7225733257","doi":"https://doi.org/10.3389/fcvm.2026.1991282"},"language":"en","primary_location":{"id":"doi:10.3389/fcvm.2026.1991282","doi":"https://doi.org/10.3389/fcvm.2026.1991282","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2026.1991282","pdf_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.1991282/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.1991282/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5022946954","display_name":"Shiyang Wei","orcid":"https://orcid.org/0009-0005-0997-0470","observed_orcids":["https://orcid.org/0009-0005-0997-0470"]},"institutions":[{"id":"https://openalex.org/I4210122818","display_name":"The Affiliated Taizhou People's Hospital of Nanjing Medical University","ror":"https://ror.org/02fvevm64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210122818"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shiyang Wei","raw_affiliation_strings":["Department of Cardiology, The Affiliated Taizhou People's Hospital of Nanjing Medical University","Taizhou School of Clinical Medicine, Nanjing Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, The Affiliated Taizhou People's Hospital of Nanjing Medical University","institution_ids":["https://openalex.org/I4210122818"]},{"raw_affiliation_string":"Taizhou School of Clinical Medicine, Nanjing Medical University","institution_ids":["https://openalex.org/I83519826"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161381647","display_name":"Lingyu Han","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210122818","display_name":"The Affiliated Taizhou People's Hospital of Nanjing Medical University","ror":"https://ror.org/02fvevm64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210122818"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Lingyu Han","raw_affiliation_strings":["Department of Cardiology, The Affiliated Taizhou People's Hospital of Nanjing Medical University","Taizhou School of Clinical Medicine, Nanjing Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, The Affiliated Taizhou People's Hospital of Nanjing Medical University","institution_ids":["https://openalex.org/I4210122818"]},{"raw_affiliation_string":"Taizhou School of Clinical Medicine, Nanjing Medical University","institution_ids":["https://openalex.org/I83519826"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5107956190","display_name":"Li Zhu","orcid":"https://orcid.org/0000-0002-8586-7249","observed_orcids":["https://orcid.org/0000-0002-8586-7249"]},"institutions":[{"id":"https://openalex.org/I4210122818","display_name":"The Affiliated Taizhou People's Hospital of Nanjing Medical University","ror":"https://ror.org/02fvevm64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210122818"]},{"id":"https://openalex.org/I83519826","display_name":"Nanjing Medical University","ror":"https://ror.org/059gcgy73","country_code":"CN","type":"education","lineage":["https://openalex.org/I83519826"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Li Zhu","raw_affiliation_strings":["Department of Cardiology, The Affiliated Taizhou People's Hospital of Nanjing Medical University","Taizhou School of Clinical Medicine, Nanjing Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiology, The Affiliated Taizhou People's Hospital of Nanjing Medical University","institution_ids":["https://openalex.org/I4210122818"]},{"raw_affiliation_string":"Taizhou School of Clinical Medicine, Nanjing Medical University","institution_ids":["https://openalex.org/I83519826"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5107956190"],"corresponding_institution_ids":["https://openalex.org/I4210122818","https://openalex.org/I83519826"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"13","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10821","display_name":"Cardiovascular Function and Risk Factors","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11638","display_name":"Cardiac tumors and thrombi","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9294000267982483},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7615000009536743},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.7174000144004822},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.684499979019165},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.5928999781608582},{"id":"https://openalex.org/C78085059","wikidata":"https://www.wikidata.org/wiki/Q641303","display_name":"Ejection fraction","level":3,"score":0.5789999961853027},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.5113999843597412},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.4731999933719635},{"id":"https://openalex.org/C36036425","wikidata":"https://www.wikidata.org/wiki/Q7846262","display_name":"Troponin","level":3,"score":0.4668999910354614},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.4406999945640564},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.40799999237060547},{"id":"https://openalex.org/C2775846464","wikidata":"https://www.wikidata.org/wiki/Q66360952","display_name":"Brain natriuretic peptide","level":3,"score":0.36959999799728394},{"id":"https://openalex.org/C50440223","wikidata":"https://www.wikidata.org/wiki/Q1475848","display_name":"Risk factor","level":2,"score":0.362199991941452},{"id":"https://openalex.org/C2775915353","wikidata":"https://www.wikidata.org/wiki/Q1571529","display_name":"Natriuretic peptide","level":3,"score":0.3605000078678131},{"id":"https://openalex.org/C2992203999","wikidata":"https://www.wikidata.org/wiki/Q1940733","display_name":"Mean blood pressure","level":4,"score":0.28200000524520874},{"id":"https://openalex.org/C144469398","wikidata":"https://www.wikidata.org/wiki/Q24785650","display_name":"Troponin T","level":3,"score":0.28029999136924744},{"id":"https://openalex.org/C2778233292","wikidata":"https://www.wikidata.org/wiki/Q2118956","display_name":"Cardiotoxicity","level":3,"score":0.2784000039100647},{"id":"https://openalex.org/C178853913","wikidata":"https://www.wikidata.org/wiki/Q1642137","display_name":"Hemodynamics","level":2,"score":0.2761000096797943},{"id":"https://openalex.org/C115725540","wikidata":"https://www.wikidata.org/wiki/Q7846263","display_name":"Troponin I","level":3,"score":0.27230000495910645},{"id":"https://openalex.org/C82789193","wikidata":"https://www.wikidata.org/wiki/Q2142611","display_name":"Relative risk","level":3,"score":0.27149999141693115},{"id":"https://openalex.org/C11783203","wikidata":"https://www.wikidata.org/wiki/Q5478027","display_name":"Framingham Risk Score","level":3,"score":0.27000001072883606},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.2648000121116638},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.2606000006198883}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fcvm.2026.1991282","doi":"https://doi.org/10.3389/fcvm.2026.1991282","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2026.1991282","pdf_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.1991282/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fcvm.2026.1991282","doi":"https://doi.org/10.3389/fcvm.2026.1991282","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fcvm.2026.1991282","pdf_url":"https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2026.1991282/pdf","source":{"id":"https://openalex.org/S2595413687","display_name":"Frontiers in Cardiovascular Medicine","issn_l":"2297-055X","issn":["2297-055X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","norway-1","oarl","poland-40","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Cardiovascular Medicine","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225733257.pdf","grobid_xml":"https://content.openalex.org/works/W7225733257.grobid-xml"},"referenced_works_count":26,"referenced_works":["https://openalex.org/W2976249548","https://openalex.org/W3113304994","https://openalex.org/W3143888266","https://openalex.org/W3165773896","https://openalex.org/W3204395813","https://openalex.org/W4214940518","https://openalex.org/W4293217929","https://openalex.org/W4313522768","https://openalex.org/W4318482201","https://openalex.org/W4319298000","https://openalex.org/W4319298030","https://openalex.org/W4319332893","https://openalex.org/W4320857052","https://openalex.org/W4381737218","https://openalex.org/W4386911040","https://openalex.org/W4396652545","https://openalex.org/W4400658937","https://openalex.org/W4401385406","https://openalex.org/W4401615622","https://openalex.org/W4402988845","https://openalex.org/W4404076187","https://openalex.org/W4409137882","https://openalex.org/W4411930213","https://openalex.org/W4414429340","https://openalex.org/W4417198783","https://openalex.org/W7155056707"],"related_works":[],"abstract_inverted_index":{"Background":[0],"Vascular":[1],"endothelial":[2],"growth":[3],"factor":[4],"receptor":[5],"tyrosine":[6],"kinase":[7],"inhibitors":[8],"(VEGFR-TKIs)":[9],"have":[10],"become":[11],"integral":[12],"to":[13,194,203,268,277],"the":[14,124,215,257,272,286,319],"treatment":[15,44,142,352],"of":[16,27,73,172],"several":[17],"solid":[18],"tumors":[19],"but":[20],"are":[21],"associated":[22,255],"with":[23,114,256],"a":[24,70,169,219],"distinctive":[25],"spectrum":[26],"cardiovascular":[28,84,130],"toxicity,":[29],"particularly":[30],"hypertension":[31,140],"and":[32,37,56,107,159,181,242,265,297,314,344],"myocardial":[33,38,298],"dysfunction.":[34],"Because":[35],"vascular":[36,296],"abnormalities":[39],"may":[40],"emerge":[41],"soon":[42],"after":[43,300,332],"initiation,":[45],"we":[46],"evaluated":[47],"whether":[48],"early":[49,339],"changes":[50,267,299,326],"in":[51],"blood":[52,90,189,233,261,312],"pressure,":[53,91,262],"cardiac":[54,93,146],"biomarkers,":[55],"echocardiographic":[57],"strain":[58,110],"could":[59],"provide":[60],"complementary":[61,304],"information":[62,305,331],"for":[63,351],"cardio-oncology":[64],"risk":[65,85],"stratification.":[66],"Methods":[67],"We":[68],"analyzed":[69,287],"retrospective":[71],"cohort":[72,167],"640":[74],"adults":[75],"initiating":[76],"axitinib,":[77],"sunitinib,":[78],"pazopanib,":[79],"sorafenib,":[80],"or":[81,138,154,291],"lenvatinib.":[82],"Baseline":[83],"factors,":[86],"prior":[87],"cardiotoxic":[88],"therapy,":[89],"high-sensitivity":[92],"troponin":[94],"I":[95],"(hs-cTnI),":[96],"N-terminal":[97],"pro-B-type":[98],"natriuretic":[99],"peptide":[100],"(NT-proBNP),":[101],"left":[102],"ventricular":[103],"ejection":[104],"fraction":[105],"(LVEF),":[106],"global":[108],"longitudinal":[109],"(GLS)":[111],"were":[112,163,179,254,318],"assessed,":[113],"repeat":[115],"evaluation":[116],"at":[117,205],"4":[118],"weeks.":[119],"The":[120,166,279],"primary":[121],"outcome":[122],"was":[123],"first":[125],"clinically":[126,151],"significant":[127,152],"cancer":[128,144],"therapy-related":[129,145],"toxicity":[131],"(CTR-CVT)":[132],"within":[133,285],"12":[134,209],"months,":[135,210],"encompassing":[136],"treatment-emergent":[137],"worsening":[139],"requiring":[141],"escalation,":[143],"dysfunction":[147],"(CTRCD),":[148],"heart":[149],"failure,":[150],"arrhythmia,":[153],"arterial":[155],"thromboembolism.":[156],"Cox":[157,221],"regression":[158],"fixed-horizon":[160],"discrimination":[161],"analyses":[162],"performed.":[164],"Results":[165],"had":[168,184],"mean":[170,198],"age":[171,223],"60.5":[173],"\u00b1":[174],"11.4":[175],"years;":[176],"360":[177],"(56.2%)":[178],"men":[180],"255":[182],"(39.8%)":[183],"baseline":[185,269,307],"hypertension.":[186],"Mean":[187],"systolic":[188,232,311],"pressure":[190,234,313],"increased":[191,271],"from":[192,201,275],"129.8":[193],"143.2":[195],"mmHg,":[196,238],"while":[197,324],"GLS":[199,244,316],"changed":[200],"\u221219.0%":[202],"\u221217.7%":[204],"week":[206],"4.":[207],"During":[208],"155":[211],"patients":[212],"(24.2%)":[213],"experienced":[214],"composite":[216],"outcome.":[217,258],"In":[218],"multivariable":[220],"model,":[222],"(HR":[224,235,246],"1.023":[225],"per":[226,237,248],"year,":[227],"95%":[228,239,251],"CI":[229,240,252],"1.008\u20131.038),":[230],"week-4":[231,260],"1.018":[236],"1.008\u20131.029),":[241],"relative":[243,315],"decline":[245,317],"1.042":[247],"percentage":[249],"point,":[250],"1.000\u20131.085)":[253],"Adding":[259],"GLS,":[263],"hs-cTnI,":[264],"NT-proBNP":[266],"variables":[270],"12-month":[273],"AUC":[274,280],"0.638":[276],"0.693.":[278],"estimates":[281],"describe":[282],"apparent":[283],"performance":[284],"cohort,":[288],"without":[289],"internal":[290],"external":[292,347],"validation.":[293],"Conclusions":[294],"Early":[295],"VEGFR-TKI":[301,342],"initiation":[302],"provided":[303],"beyond":[306],"clinical":[308],"risk.":[309],"Week-4":[310],"strongest":[320],"independent":[321],"dynamic":[322],"markers,":[323],"biomarker":[325],"added":[327],"more":[328],"limited":[329],"incremental":[330],"mutual":[333],"adjustment.":[334],"These":[335],"findings":[336],"support":[337],"multimodal":[338],"surveillance":[340],"during":[341],"therapy":[343],"warrant":[345],"prospective":[346],"validation":[348],"before":[349],"use":[350],"decisions.":[353]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-11T00:00:00"}
